Advertisement
Home Tags Liver Disease: Misc.

Tag: Liver Disease: Misc.

The proportion of liver transplants for alcohol-associated liver disease increased from 2002 to 2016

Liver Transplants for Alcohol-Linked Disease Increased From 2002 to 2016

0
Much of the increase due to decrease in hepatitis C virus infection as indication for transplant
A nurse-led primary care intervention can increase the number of new diagnoses of liver disease

Nurse-Led Program in Primary Care Can Up Detection of Liver Dz

0
More incident cases identified in intervention arm with nurse-led primary care-based liver clinics
The average liver proton density fat fraction normalizes by a mean of 22.5 weeks after bariatric surgery

Liver Proton Density Fat Fraction Drops After Bariatric Surgery

0
New MRI technique to monitor liver fat shows normalization after a mean of 22.5 weeks
Accepting a liver from an older liver donor is associated with long-term survival benefit

ACS: Accepting Liver From Older Donor Better Than Waiting

0
Candidates who accept organ from older donor have lower mortality within and beyond 90 days
Web-based programs may be effective in helping patients make lifestyle changes to control non-alcoholic fatty liver disease

Web-Based Lifestyle Program Works for Liver Disease Patients

0
Similar weight, liver enzyme improvements seen with group- and web-based programs for NAFLD patients
For patients with nonalcoholic fatty liver disease

Modest Alcohol Consumption May Reduce Mortality in NAFLD

0
But drinking ≥1.5 drinks/day linked to increased mortality after adjustment for multiple confounders
Liver disease-related deaths

Liver Disease-Related Deaths Up Sharply From 1999 to 2016

0
Adults aged 25 to 34 show greatest relative increase in mortality, driven by alcoholic cirrhosis
Nearly one-third of patients with primary biliary cholangitis who had had an inadequate response to ursodeoxycholic acid alone achieved a complete biochemical response with the addition of bezafibrate to treatment

Addition of Bezafibrate Beneficial in Primary Biliary Cholangitis

0
Complete biochemical response in 31 percent of patients unresponsive to ursodeoxycholic acid alone
The health care costs associated with nonalcoholic fatty liver disease are considerable

High Costs for Diagnosis, Care of Nonalcoholic Fatty Liver Disease

0
Costs were significantly higher than total annual costs per matched control with similar comorbidities
Doptelet (avatrombopag) has been approved by the U.S. Food and Drug Administration to treat adults with chronic liver disease who are slated to have a medical or dental procedure.

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

0
Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure